Research Journal of Pharmacy and Technology
SCOPUS
  • Year: 2025
  • Volume: 18
  • Issue: 11

Stability Indicating RP-HPLC Method Development and Validation for Simultaneous Estimation of Silodosin and Tadalafil in Synthetic Mixture

  • Author:
  • J. Amitkumar Vyas1, V. Anjali Ramani1,*, M. Harshal Vadile1, I. Ajay Patel1, V. Ashvin Dudhrejiya1, R. Sunny Shah2, J. Urvi Chotaliya1, Shweta Prajapati1, B. Devang Sheth3
  • Total Page Count: 5
  • Published Online: Mar 31, 2026
  • Page Number: 5288 to 5292

1B. K. Mody Government Pharmacy College, Rajkot-360003, Gujarat, India

2Government Pharmacy College, Gandhinagar, Gujarat, India

3L. M. College of Pharmacy, Ahmedabad, Gujarat, India

*Corresponding Author E-mail: amitvyas77@gmail.com

Online published on 31 March, 2026.

Abstract

This study developed an RP-HPLC method to simultaneously determine Silodosin and Tadalafil. Using a Thermo BDS C18 column with a mobile phase of dipotassium hydrogen phosphate buffer and acetonitrile (60:40), the method achieved retention times of 2.905 minutes for Silodosin and 5.082 minutes for Tadalafil. The method exhibited excellent linearity with a correlation coefficient of 0.999 for both drugs, with Silodosin ranging from 1.6-200µg/mL and Tadalafil from 1-125µg/mL. The accuracy was between 99.24% and 100.97% for Silodosin and 99.92% and 100.13% for Tadalafil. The limits of detection were 0.40μg/mL for Silodosin and 0.20μg/mL for Tadalafil, while the limits of quantification were 1.21μg/mL and 0.63μg/mL, respectively. This method is precise and accurate, making it suitable for routine analysis of these drugs.

Keywords

Force Degradation, Hydrolysis, ICH Guideline (Q2R1), Silodosin, Tadalafil